Israel’s financial system shows “high resilience” despite the country’s military conflicts and ongoing geopolitical uncertainty that have persisted for more than a year, the Bank of Israel said in a report on Tuesday. The banking sector’s profits have been boosted …
Israeli cybersecurity firms raised $4 billion in 2024, more than double that of 2023, led by firms seeking to protect the cloud along with a surge in artificial intelligence, global venture capital firm YL Ventures said on Tuesday. Cybersecurity has …
Israeli cyber security startup Claroty is preparing a possible U.S. initial public offering in 2025 at a valuation of $3.5 billion, the Calcalist financial daily reported on Tuesday. Calcalist, without citing sources, said Claroty was currently valued at $2.5 billion …
Aviation war insurers have given notice to cancel cover for some airlines domiciled in Israel and Lebanon because of the conflict in the region, with some cancellations already taking effect, three industry sources with direct knowledge of the matter said. …
Financial services company Vesttoo said on Tuesday it was laying off about 75% of its staff and closing some offices in Asia, as it tries to recover from a scandal over a fraudulent letter of credit used as collateral in …
A consortium led by Abu Dhabi state holding firm ADQ are in advanced negotiations to acquire a controlling stake in Israeli financial firm Phoenix Group in a deal that values the company at around 9.2 billion shekels ($2.70 billion), the …
Teva Pharmaceutical Industries Lts. will pay up to $523 million to New York State as part of a nationwide settlement of lawsuits alleging the company helped fuel the U.S. opioid epidemic. The settlement with New York adds an additional $300 …
Teva Pharmaceutical Industries expects to finalize an opioid settlement in the United States by year-end and start paying in 2023, its chief executive said on Sunday, while confirming he was unlikely to renew his contract next year. After years of …
Teva Pharmaceutical Industries believes it would have to pay around $2.6 billion in cash and medicine to settle thousands of lawsuits alleging it and other drug companies fueled the U.S. opioid epidemic. On the heels of two more state settlements …
